文献速递乳腺乳腺X线

美国65岁及以上女性数字二维乳腺X线摄影与断层合成筛查乳腺X线摄影的比较

Digital 2D versus Tomosynthesis Screening Mammography among Women Aged 65 and Older in the United States.
PubMed 文献 · Radiology · 2019-04-02

该回顾性研究比较了65岁及以上女性中数字乳腺X线摄影(DM)与数字乳腺断层合成(DBT)的筛查性能指标。DBT组异常解读率更低(5.7% vs 5.8%,AOR 0.88,P < .001)、阳性预测值1更高(14.5% vs 11.9%,AOR 1.26,P = .03)、特异度更高(95.1% vs 94.8%,AOR 1.18,P < .001),而癌检出率两组无差异(6.9 vs 8.2/1000次检查,AOR 1.13,P = .23)。

要点

  • 65岁及以上女性中,DBT较DM异常解读率更低、特异度更高、阳性预测值1更高。
  • DBT与DM的癌检出率无显著差异(6.9 vs 8.2/1000次检查,AOR 1.13,P = .23)。
  • DBT组浸润癌占比更高(81.1% vs 74.4%,P = .06)、淋巴结阳性癌更少(10.2% vs 16.6%,P = .054),均未达统计学显著。

核心结论

  • 在65岁及以上女性中,整合数字乳腺断层合成带来了性能指标的改善,表现为异常解读率更低、阳性预测值1更高和特异度更高。

研究设计与样本

  • 回顾性研究,连续纳入2008年3月至2011年2月的DM组筛查乳腺X线摄影(15 019名女性,平均年龄72.7岁±6.3)和2013年1月至2015年12月的DBT组筛查乳腺X线摄影(20 646名女性,平均年龄72.1岁±5.9),计算癌检出率、异常解读率、阳性预测值、敏感度和特异度,并采用多变量logistic回归模型比较两组性能指标。

诊断标准与关键数值

  • 癌检出率DM组6.9/1000次检查 vs DBT组8.2/1000次检查(AOR 1.13,P = .23);异常解读率DM组5.8% vs DBT组5.7%(AOR 0.88,P < .001);阳性预测值1 DM组11.9% vs DBT组14.5%(AOR 1.26,P = .03);特异度DM组94.8% vs DBT组95.1%(AOR 1.18,P < .001);浸润癌占比DM组74.4% vs DBT组81.1%(P = .06);淋巴结阳性癌DM组16.6% vs DBT组10.2%(P = .054)。

临床应用与阅片要点

  • 在65岁及以上女性的筛查乳腺X线摄影中,DBT较DM异常解读率更低、阳性预测值1更高、特异度更高,而癌检出率两组无显著差异;DBT组浸润癌占比更高和淋巴结阳性癌更少均未达统计学显著。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Although breast cancer incidence and mortality rates increase with advancing age, there are limited data on the benefits and risks of screening mammography in older women and on the performance of two-dimensional digital mammography (DM) and digital breast tomosynthesis (DBT) in older women. Purpose To compare performance metrics of DM and DBT among women aged 65 years and older. Materials and Methods For this retrospective study, consecutive screening mammograms in patients aged 65 years and older from March 2008 to February 2011 (DM group) and from January 2013 to December 2015 (DBT group) were reviewed. Cancer detection rate, abnormal interpretation rate, positive predictive values, sensitivity, and specificity were calculated. Multivariable logistic regression models were fit to compare performance metrics in the DM versus DBT groups. Results The DM group had 15 019 women (mean age ± standard deviation, 72.7 years ± 6.3), and the DBT group had 20 646 women (mean age, 72.1 years ± 5.9). After adjusting for multiple variables, there was no difference in cancer detection rate between the DM and DBT groups (6.9 vs 8.2 per 1000 examinations; adjusted odds ratio [AOR], 1.13; P = .23). Compared with the DM group, the DBT group had a lower abnormal interpretation rate (5.7% vs 5.8%; AOR, 0.88; P < .001), higher positive predictive value 1 (14.5% vs 11.9%; AOR, 1.26; P = .03), and higher specificity (95.1% vs 94.8%; AOR, 1.18; P < .001). The DBT group had a higher proportion of invasive cancers relative to in situ cancers (81.1% vs 74.4%; P = .06) and fewer node-positive cancers (10.2% vs 16.6%; P = .054) than did the DM group. Conclusion In women aged 65 years and older, integration of digital breast tomosynthesis led to improved performance metrics, with a lower abnormal interpretation rate, higher positive predictive value 1, and higher specificity. © RSNA, 2019 See also the editorial by Philpotts and Durand in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Bahl M, Pinnamaneni N, Mercaldo S, et al. Digital 2D versus Tomosynthesis Screening Mammography among Women Aged 65 and Older in the United States. Radiology. 2019. PMID: 30938625. doi:10.1148/radiol.2019181637

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。